AGITO MEDICAL A/S: Financial statements 2017
CVR: 27770851
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
AGITO MEDICAL A/S (CVR 27770851) has filed annual accounts for 2017. In 2017, the company reported a gross profit of EUR 6,037,679 and a net result of EUR 475,342 compared with EUR 1,793,259 the year before. That is a decrease of 8.9% compared with the year before. Equity in the 2017 report amounted to EUR 4,548,572. The solvency ratio was 24.7%. The company had 41 employees in the financial year.
- Gross Profit
- EUR 6,037,679
- Profit/Loss
- EUR 475,342
- Equity
- EUR 4,548,572
- Total Assets
- EUR 18,395,951
- Employees
- 41
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 6M EUR | 475K EUR | 4.5M EUR | 41 |
| 2016 | - | 6.6M EUR | 1.8M EUR | 4.1M EUR | 39 |
| 2015 | - | 4.2M EUR | 353K EUR | 2.8M EUR | 37 |
| 2014 | - | 2.7M | -1.1M | 2.4M | 32 |
| 2013 | - | 3M | 279K | 3.6M | 22 |
Official annual report
Keep an eye on AGITO MEDICAL A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
AGITO MEDICAL A/S has published its annual report for 2016. Gross profit came to DKK 6,628,536, and the net result was DKK 1,793,259.
As of May 4, 2017, Dion Møberg Eriksen has joined the board of directors of AGITO MEDICAL A/S.
As of May 4, 2017, Steen Lindequist has left the board of directors of AGITO MEDICAL A/S.
About AGITO MEDICAL A/S
AGITO MEDICAL A/S is a Danish company of the type Aktieselskab based in Nørresundby, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named AGITO MEDICAL ApS. The management consists of Brian Fisker. The board consists of Bjørn August Kildegaard Gerhardt (chair), Benjamin William Goodger and Brian Fisker. The company is owned by Acorn Bidco ApS. The company has 43 employees (2026). In 2025, the company reported a gross profit of EUR 9,643,000 and a net result of EUR -5,126,000 compared with EUR -3,406,000 the year before. Equity in the 2025 report amounted to EUR 17,758,000.
